Siren »

Alibaba Group Holding shares owned by Siren

Quarter-by-quarter ownership of Alibaba Group Holding (BABA) shares owned by Siren from 13F filings

Historical chart of Siren investment in Alibaba Group Holding

Tip: Access up to 7 years of quarterly data

All positions including Alibaba Group Holding held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alibaba Group Holding by Siren

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.8M 50k 95.98

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
Erasca (ERAS)
Veradermics Common Stock (MANE)
Tango Therapeutics (TNGX)
Revolution Medicines (RVMD)
Bicara Therapeutics (BCAX)
Arrowhead Pharmaceuticals (ARWR)
BeOne Medicines Sponsored Ads (ONC)
Edgewise Therapeutics (EWTX)
Rhythm Pharmaceuticals (RYTM)
Lexicon Pharmaceuticals Com New (LXRX)
Enliven Therapeutics (ELVN)
Spyre Therapeutics Com New (SYRE)
Parabilis Medicines

View all positions for Siren

Top funds holding Alibaba Group Holding

Jane Street
Susquehanna International
Citadel Advisors
PRIMECAP Management Company
UBS Group
Hsbc Holdings
Barclays
Goldman Sachs Group
Dodge & Cox
SIH Partners, L
Capula Management
Morgan Stanley
Ubs Global Asset Management Americas
Fisher Investments
Bank of America Corporation

View all funds holding Alibaba Group Holding